GENFLOW BIOSCIENCES PLC Logo

GENFLOW BIOSCIENCES PLC

A biotechnology company developing gene therapies that target the aging process.

GENF | IL

Overview

Corporate Details

ISIN(s):
GB00BP2C3V08
LEI:
213800HVOFXRXVEGDN62
Country:
United Kingdom
Address:
6 HEDDON STREET, W1B 4BT LONDON

Description

Genflow Biosciences PLC is a biotechnology company developing gene therapies that target the aging process. The company's primary mission is to slow or halt aging and reduce the incidence of age-related diseases in both humans and dogs, thereby extending healthspan. Its lead therapeutic candidate, GF-1002, is a gene therapy that delivers a centenarian variant of the Sirtuin 6 (SIRT6) gene. This specific gene variant has been identified in individuals who live to 100 years or more and has demonstrated promising results in pre-clinical studies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-04-09 16:20
NOTIFICATION OF MAJOR HOLDINGS
English 21.9 KB
2024-04-09 15:59
NOTIFICATION OF MAJOR HOLDINGS
English 21.9 KB
2024-04-04 08:00
Successful Placing and Subscription
English 80.2 KB
2024-03-21 08:03
NOTIFICATION OF MAJOR HOLDINGS
English 21.9 KB
2024-03-21 08:00
Publication of a Key European Patent
English 17.8 KB
2024-02-01 08:00
Highlights and Key Priorities
English 20.5 KB
2024-01-18 13:03
Two Non-Dilutive Research Grant Awards
English 13.9 KB
2023-11-08 08:00
Appointment of Joint Broker
English 10.9 KB
2023-11-02 19:04
ANNUAL REPORT AND FINANCIAL STATEMENTS
English 430.7 KB
2023-11-02 19:04
ANNUAL REPORT AND FINANCIAL STATEMENTS
English 1.2 MB
2023-09-28 08:00
Half-year Report
English 237.3 KB
2023-09-20 08:00
Company Update
English 14.7 KB
2023-07-13 12:48
Annual Financial Report
English 577.1 KB
2023-07-13 12:48
Annual Financial Report
English 1.9 MB
2023-06-13 08:00
Admittance to trading on the OTCQB Venture Market
English 13.1 KB

Automate Your Workflow. Get a real-time feed of all GENFLOW BIOSCIENCES PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GENFLOW BIOSCIENCES PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GENFLOW BIOSCIENCES PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.